The Unlikely Development of CAR T Cells: a Brief History and Prospects for the Future

Keio J Med. 2023;72(1):26. doi: 10.2302/kjm.ABSTRACT_72_1-1.ABSTRACTThe quest to cure cancer has been one of the Holy Grails of medicine. The discovery I am going to share with you, CAR T cells, is a promising new form of therapy of cancer that offers the prospect of curing cancer using the immune system. CAR T cells are the first form of synthetic biology to enter the practice of medicine. The notion of using the immune system to fight cancer is an old idea. Over a century ago, bacteria were ground up and injected into patients with late-stage cancers, and occasionally the cancer would disappear. However, we now have precise tools for genetic editing and gene insertion like CRISPR/Cas9 to rewrite the DNA code, offering the possibility to improve the immune system over what has evolved in a Darwinian fashion. In 2017 for the first time, CAR T cells were approved for the treatment of cancer. Today they are used worldwide in more than 15,000 patients and they offer the promise to move beyond cancer to other fields of medicine such as autoimmune disease and heart disease. Here I will discuss the promises and challenges faced by the evolving CAR T cell industry.PMID:36967127 | DOI:10.2302/kjm.ABSTRACT_72_1-1
Source: The Keio Journal of Medicine - Category: Universities & Medical Training Authors: Source Type: research